Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Therapy in Rectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT07509632
What this trial is testing

Predicting Pathological Complete Response in Rectal Cancer Using Machine Learning

Who this might be right for
Rectal CancersPathological Complete ResponseNeoadjuvant Chemoradiotherapy+1 more
Peking University People's Hospital 320
Early research (Phase 1)Ended earlyNCT02910843
What this trial is testing

Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Swiss Cancer Institute 25
Testing effectiveness (Phase 2)Looking for participantsNCT07735624
What this trial is testing

RECTIFY-1: Neoadjuvant Botensilimab + Balstilimab in MSS/pMMR Early Rectal Cancer

Who this might be right for
Early Rectal CancerStage I Rectal CancerMicrosatellite Stable Rectal Carcinoma
Dana-Farber Cancer Institute 16
Not applicableStudy completedNCT04096118
What this trial is testing

Relationship Between Lymph Node Ratio and Survival Rate in Preoperative Chemoradiation Rectal Cancer Patients

Who this might be right for
Rectal Cancer
Mahidol University 160
Early research (Phase 1)Study completedNCT03152370
What this trial is testing

Preoperative Radiotherapy and E7046 in Rectum Cancer

Who this might be right for
Neoadjuvant Therapy in Rectal Cancer
Adlai Nortye Biopharma Co., Ltd. 29
Large-scale testing (Phase 3)Not Yet RecruitingNCT07740720
What this trial is testing

The Duration of Dostarlimab in Untreated Mismatch Repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H) Locally Advanced Rectal Cancer

Who this might be right for
Neoplasms, Rectal
GlaxoSmithKline 90
Testing effectiveness (Phase 2)UnknownNCT02887313
What this trial is testing

FOLFOX6 Totally Neoadjuvant Chemoradiation Therapy in Locally Advanced Rectal Cancer: A Real World Study

Who this might be right for
Rectal Cancer
Sun Yat-sen University 200
Not applicableStudy completedNCT05495308
What this trial is testing

"Oncologic Results and Risk Factors for Recurrence in Patients With Locally Advanced Rectal Cancer and Pathologic Complete Response After Neoadjuvant Treatment. Results From an Observational Retrospective Multicenter Long-term Follow-up Study".

Who this might be right for
Rectal Cancer, AdenocarcinomaRectal Cancer Stage IIRectal Cancer Stage III+2 more
Hospital San Carlos, Madrid 4
Not applicableLooking for participantsNCT04743102
What this trial is testing

Multi-points and Full-thickness Biopsy in the Diagnosis of cCR After Neoadjuvant Therapy for Rectal Cancer

Who this might be right for
Rectal CancerNeoadjuvant TherapyComplete Remission+1 more
Beijing Chao Yang Hospital 260
Not applicableEnrolling By InvitationNCT06883084
What this trial is testing

Clinical Relevance of Pathologic Regression IN Lymph Node for Locally Advanced Rectal Cancer

Who this might be right for
Rectal CancerLymph Node Metastasis
Yanhong Deng 1,080
Testing effectiveness (Phase 2)Looking for participantsNCT03926338
What this trial is testing

Neoadjuvant Toripalimab With or Without Celecoxib in dMMR/MSI-H Colorectal Cancer

Who this might be right for
Colorectal CancerMismatch Repair-deficient (dMMR)Microsatellite Instability-high (MSI-H)+1 more
Sun Yat-sen University 270
Not applicableLooking for participantsNCT07260526
What this trial is testing

Response-adapted Total Neoadjuvant Therapy Guided by Induction Chemotherapy in Early- and Intermediate-risk Low Rectal Cancer for Implementation of a Watch-and-wait Strategy

Who this might be right for
Rectal Cancer
West China Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT07448077
What this trial is testing

Short-course Radiotherapy in TNT Combined With Enlonstobart for pMMR LARC

Who this might be right for
Efficacy and Safety of Short-course Radiotherapy in Total Neoadjuvant Therapy Combined With Enlonstobart for pMMR Locally Advanced Rectal Cancer
Hebei Medical University Fourth Hospital 128
Not applicableUnknownNCT05688033
What this trial is testing

Dosimetric Limitation of Pelvic Bone and Peritoneal Space in Rectal Cancer Patients During Chemoradiotherapy

Who this might be right for
Rectal Cancer
Fudan University 200
Not applicableUnknownNCT04717947
What this trial is testing

Interval Between Neoadjuvant Therapy and Surgery in the Treatment of Locally Advanced Rectal Cancer (CRONOS)

Who this might be right for
Rectal CancerNeoadjuvant Therapy
Hospital Clinic of Barcelona 911
Testing effectiveness (Phase 2)Looking for participantsNCT04643366
What this trial is testing

Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer

Who this might be right for
Rectal Cancer
Virginia Commonwealth University 64
Not applicableActive Not RecruitingNCT06688786
What this trial is testing

A Pospective, Single-arm, Multicenter Clinical Trial Evaluating Preoperative Neoadjuvant mFOLFOX6 Chemotherapy in Combination With PD1 Monoclonal Antibody in MSS/pMMR Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer (LARC)
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 30
Not applicableLooking for participantsNCT04804956
What this trial is testing

Mesorectal Microbiome and Metabolome as a Prognostic Factor in Patients With Rectal Cancer

Who this might be right for
Rectal Cancer
University Hospital of Girona Dr. Josep Trueta 100
Not applicableStudy completedNCT04319354
What this trial is testing

Evaluation of cfDNA as a Marker of Response in Rectal Cancer

Who this might be right for
Cancer of Rectum
Hospital Pedro Hispano 50
Testing effectiveness (Phase 2)Looking for participantsNCT05555888
What this trial is testing

The Combination of Immunotherapy and Neoadjuvant Short-course Radiotherapy in Early Rectal Cancer

Who this might be right for
Early Low Rectal Cancer
Fudan University 34
Next Page